´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26±³À°ÀÏÀÚ : 2021-11-26
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540
À̸ÞÀÏ :
kalc@lungca.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 08:00~08:50 Overcoming Resistance to Immune-Targeted Therapies Fabrice Barlesi(Gustave Roussy France)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 08:50~09:10 Radial EBUS Guided TBLB for Peripheral Pulmonary Lesions June Hong Ahn(Yeungnam Univ.)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 09:10~09:30 ENB-Guided Preoperative Localization for Small Pulmonary Nodules In Kyu Park(Seoul National Univ.)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 09:30~09:50 ENB-Guided Ablative Therapy Calvin S. H. Ng(The Chinese Univ. of Hong Kong Hong Kong)
ÈÞ½Ä 11-26 ¿Â¶óÀÎ 09:50~10:10 ()
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 10:10~10:35 How to Handle Oligometastatic Disease in Non-Small Cell Lung Cancer Hauke Winter(Universitätsklinikum Heidelberg Germany)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 10:35~11:00 Surgical Role in Oligometastasis to Spines Seung-Jae Hyun(Seoul National Univ.)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 11:00~11:25 Local Ablative Therapy with Radiation in Extra-Thoracic Visceral Oligometastasis Jin Ho Kim(Seoul National Univ.)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 11:25~12:10 Lorlatinib: Clinical Data and Implications for the Sequential Therapy in Anaplastic Lymphoma Kinase+ Non-Small Cell Lung Cancer Benjamin J Solomon(Peter MacCallum Cancer Centre Australia)
½Ä»ç 11-26 ¿Â¶óÀÎ 12:10~13:00 ()
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 13:00~13:25 Oligometastasis with Radiotherapy and Immunotherapy Ralph Weichselbaum(The University of Chicago Medicine USA)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 13:25~13:50 T Cell Metabolism and CAR-T Hongbo Chi(St. Jude Children)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 13:50~14:15 Cold to Hot Conversion In-San Kim(KIST)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 14:15~14:40 How Can We Enhance the Treatment Responses of Anti-PD-1 in Cancers? Su-Hyung Park(KAIST)
ÈÞ½Ä 11-26 ¿Â¶óÀÎ 14:40~15:00 ()
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 15:00~15:25 Predictive Biomarkers to Immune Checkpoint Blockade Hye Ryun Kim(Yonsei Univ)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 15:25~15:50 Resistance Mechanisms to Immune Checkpoint Blockade Se-Hoon Lee(Sungkyunkwan Univ.)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 15:50~16:15 Novel Immune Checkpoint Blockade Se Hoon Park(Sungkyunkwan Univ.)
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 16:15~16:40 Immunotherapy Beyond Immune Checkpoint Blockade Ross Soo(National Univ. Cancer Institute Singapore)
ÈÞ½Ä 11-26 ¿Â¶óÀÎ 16:40~16:50 ()
±³À°½Ã°£ 11-26 ¿Â¶óÀÎ 16:50~17:40 Shifting Paradigm in EGFRm Non-Small Cell Lung Cancer Treatment from Early to Advance Stage Patients Helena A. Yu(MSKCC USA)